Filters

Pp-251 manufacturers

Filters

None products found

pp-251

Solution for infusion

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Neoplasm, Cancer, Pancreas tumor, Small-cell lung cancer, Ovary tumor, Gastrointestinal disease Clinical stage: Phase 2 Modality: Small molecule inhibitor Mechanism & Target: Anticancer permeability enhancer, Anticancer antimetabolite, Cell cycle inhibitor, Anticancer chemosensitizer Route & form: Oral Differentiation: medicine is a differentiated SN-38 formulation designed to enhance tumor-selective exposure and systemic pharmacologic activity in solid tumors, particularly small cell lung cancer (SCLC)."
Manufacturer #39669

Clinical-stage company developing IgG-cleaving enzyme therapies for transplant and autoimmune disease. Lead program targets antibody-mediated rejection desensitization prior to kidney transplant. Advances Phase 3 pivotal programs with global regulatory development partnerships.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.